Small Molecule Multi-Targeted Kinase Inhibitor RGB-286638 Triggers P53-Dependent and -Independent Anti-Multiple Myeloma Activity through Inhibition of Transcriptional CDKs

Small molecule multi-targeted CDK inhibitors (CDKIs) are of particular interest due to their potent antitumor activity independent of p53 gene alterations. P53 deletion is associated with a very poor prognosis in multiple myeloma (MM). In this regard, we tested the anti-MM activity of RGB-286638, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cirstea, Diana, Hideshima, Teru, Santo, Loredana, Eda, Homare, Mishima, Yuko, Nemani, Neeharika, Hu, Yiguo, Mimura, Naoya, Cottini, Francesca, Gorgun, Gullu, Ohguchi, Hiroto, Suzuki, Rikio, Loferer, Hannes, Munshi, Nikhil C., Anderson, Kenneth C., Raje, Noopur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928098/
https://www.ncbi.nlm.nih.gov/pubmed/23807770
http://dx.doi.org/10.1038/leu.2013.194

Ejemplares similares

Ejemplares similares